Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon

Area of Science:

• Genomics
• Cancer Biology
• Drug Discovery

Background:

• Precision oncology requires identifying novel therapeutic targets for specific cancer molecular subtypes.
• CRISPR/Cas9 screens have advanced the discovery and validation of cancer targets.
• Numerous cancer vulnerabilities linked to molecular features remain unexplored.

Purpose of the Study:

• To identify gene dependencies associated with common cancer genomic amplifications using CRISPR/Cas9 screen data.
• To prioritize candidate therapeutic targets by integrating gene dependency, druggability, and subcellular location data.
• To discover potential predictive biomarkers for gene dependency based on gene expression.

Main Methods:

• Utilized CRISPR/Cas9 screening data from 954 cancer cell lines.
• Analyzed gene dependencies in relation to 16 common cancer genomic amplifications.
• Integrated gene dependency, druggability, and subcellular localization data for target prioritization.
• Examined the correlation between gene expression and gene dependency.

Main Results:

• High-copy-number genomic amplifications frequently induce multiple collateral gene dependencies within the amplified region.
• Identified a set of druggable targets specific to chromosomal regions with amplifications.
• Discovered genes whose expression levels may serve as predictive biomarkers for dependency.
• Established a framework for prioritizing therapeutic targets based on genomic amplification context.

Conclusions:

• This study provides a catalog of druggable targets tailored for specific genomic amplifications.
• The findings enable the development of targeted therapies for amplified tumors.
• Gene expression analysis offers a route to identify biomarkers predicting therapeutic response.